Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity

J Clin Endocrinol Metab. 1977 Nov;45(5):1124-7. doi: 10.1210/jcem-45-5-1124.

Abstract

Glucose, insulin and somatostatin infusion over 2 hours effectively suppressed endogenous secretion of insulin, glucagon and growth hormones. Steady state plasma glucose level (SSPG) which should be inversely proportional to insulin sensitivity was obtained. In 6 adult-onset non-obese untreated diabetics, mean value of insulin sensitivity indices was significantly reduced compared with normal. In 5 insulin-treated diabetics and in 5 subjects with borderline glucose tolerance including 2 obese subjects, insulin sensitivity for glucose utilization was also significantly diminished.

MeSH terms

  • Blood Glucose / analysis*
  • Diabetes Mellitus / blood*
  • Diabetes Mellitus / drug therapy
  • Glucose / administration & dosage*
  • Glucose Tolerance Test
  • Humans
  • Insulin / administration & dosage*
  • Insulin, Long-Acting / therapeutic use
  • Somatostatin / administration & dosage*

Substances

  • Blood Glucose
  • Insulin
  • Insulin, Long-Acting
  • Somatostatin
  • Glucose